During the first month, patients commonly experience mild to moderate nausea, which typically improves with continued use
This level suits researchers primarily interested in metabolic health improvements like insulin sensitivity and lipid panel normalization, where extreme weight loss is not the primary goal
However, emerging data and mechanistic plausibility suggest that certain populations may be at higher risk of suboptimal intake or depletion, particularly with prolonged therapy, rapid weight loss, restricted dietary variety or pre-existing marginal nutrient status
Mounjaro and Wegovy vs
You can do the same thing with GIP, GCG and peptide tyrosine tyrosine, which also play a role in appetite suppression
Comparing Claims to Reality Swipe right on mobile to scroll the table below